#treatment - Techseriesinsight

Medical equipment setup in a hospital or laboratory setting, including monitors, infusion pumps, and diagnostic devices in a sterile, blue-lit environment."

June 30, 2025
PRNewswire
Healthcare, News

InterShunt Enrolls First Patient in New Heart Failure Study

InterShunt Technologies, Inc., a medical device company focused on developing minimally invasive treatments for heart failure, has officially kicked off its latest clinical study, the EASE HF2 Early Feasibility...

June 20, 2025
PRNewswire
Biotechnology, News

Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new analyses from a Phase 4 randomized withdrawal study demonstrating significant patient-reported improvements in health-related quality of life and functional measures among...

June 13, 2025
PRNewswire
Biotechnology

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

On June 12, Keymed Biosciences Inc. (HKEX: 02162) announced that Prof. Jun Shi’s research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of Hematology,...

June 12, 2025
PRNewswire
Biotechnology

Sobi share new clinical data across multiple hematologic diseases at EHA 2025

Sobi® (STO: SOBI) will present data at the 30th EHA (European Haematology Association) hybrid congress, in Milan, Italy (12-15 June). The congress will feature the latest advances in the treatment of diffuse...

June 11, 2025
PRNewswire
Biotechnology

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

TC BioPharm (Holdings) PLC (NASDAQ: TCBP), a clinical-stage biotechnology company pioneering gamma delta T cell therapies for the treatment of cancer, today announced the first patient treated in Cohort B, presenting with detectable...

June 10, 2025
PRNewswire
Healthcare

New research reveals a deadly fungal pathogen’s vulnerabilities

Fungal infections, particularly in immunocompromised individuals, are responsible for nearly four million deaths annually however, current treatments are limited and are frequently ineffective. Now, scientists at the Stowers Institute for Medical...

June 5, 2025
PRNewswire
Artificial Intelligence

Stand Up To Cancer and SandboxAQ Launch Collaboration to Advance Treatment Innovation

Stand Up To Cancer® (SU2C) and SandboxAQ today announced a collaboration that brings SandboxAQ’s Large Quantitative Models (LQMs) to SU2C-funded cancer research projects. The initiative aims to accelerate the development of new treatments. SU2C...

May 30, 2025
PRNewswire
Healthcare

National Awareness Campaign Highlighting the Future of Cancer Care

Cancer care is evolving and with it, the stories of those impacted are reshaping how we understand healing, advocacy, and support. Mediaplanet is proud to launch the Future of...

May 30, 2025
PRNewswire
Biotechnology

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and...

May 29, 2025
PRNewswire
Biotechnology

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson’s Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Ltd. (NYSE: BHVN) (“Biohaven”), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies to treat a broad range of rare and common diseases,...